Bone Biologics Corp — Form 8-K
Filed September 16, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 92/100
What the filing says
On September 10, 2026, Bone Biologics Corp (public market value ~$7.2M) received notice of delisting or failure to satisfy continued listing standards. The 8-K filing Item 3.01 indicates the company has been notified of a potential transfer of listing or delisting. No specific cure period, financial metrics, or remediation plan details are disclosed in the filing text provided.
Why this rating
Delisting is existential threat for small-cap; loss of public market access catastrophic for $7.2M company. Stock likely to zero.
Extracted items
Price action (we called it negative)
at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from September 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.